Drug: oxaliplatin Quarter: 2016Q3
Total Records: 864 Number of Pages: 44
DRUGNAME | PT | EventCount |
---|---|---|
OXALIPLATIN. | Fibrin degradation products increased | 1 |
OXALIPLATIN. | Focal nodular hyperplasia | 1 |
OXALIPLATIN. | Formication | 1 |
OXALIPLATIN. | Gastric haemorrhage | 1 |
OXALIPLATIN. | Gastric perforation | 1 |
OXALIPLATIN. | Gastrointestinal necrosis | 1 |
OXALIPLATIN. | Gastrointestinal perforation | 1 |
OXALIPLATIN. | Generalised oedema | 1 |
OXALIPLATIN. | Grip strength decreased | 1 |
OXALIPLATIN. | Haematemesis | 1 |
OXALIPLATIN. | Haemodynamic instability | 1 |
OXALIPLATIN. | Haemolysis | 1 |
OXALIPLATIN. | Hepatic calcification | 1 |
OXALIPLATIN. | Hepatic cirrhosis | 1 |
OXALIPLATIN. | Hepatic enzyme increased | 1 |
OXALIPLATIN. | Hepatic neoplasm | 1 |
OXALIPLATIN. | Hepatic steatosis | 1 |
OXALIPLATIN. | Hepatitis | 1 |
OXALIPLATIN. | Hepatitis acute | 1 |
OXALIPLATIN. | Hepatitis toxic | 1 |
Total Records: 864 Number of Pages: 44